Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C
Yong Hwang, Won Kim, So Young Kwon, Hyung Min Yu, Jeong Han Kim, Won Hyeok Choe
Korean J Intern Med. 2015;30(6):792-800.   Published online 2015 Oct 30     DOI: https://doi.org/10.3904/kjim.2015.30.6.792
Citations to this article as recorded by Crossref logo
Dynamic Changes of Growth and Thyroid Function in Young Children With Chronic Hepatitis B Treated With Peginterferon Monotherapy
Qiufeng He, Chuangjie Mao, Zhili Chen, Fangfang Duan, Liang Huang, Rong Hu, Yang Deng, Jun Cheng, Song Yang, Yilan Zeng
Pediatric Infectious Disease Journal.2024;[Epub]     CrossRef
A systematic review and meta-analysis of endocrine-related adverse events associated with interferon
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen, Yiming Mu
Frontiers in Endocrinology.2022;[Epub]     CrossRef
Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity
R. Rodia, P. E. Meloni, C. Mascia, C. Balestrieri, V. Ruggiero, G. Serra, M. Conti, M. Loi, F. Pes, S. Onali, A. Perra, R. Littera, F. Velluzzi, S. Mariotti, L. Chessa, F. Boi
Journal of Endocrinological Investigation.2022; 46(2): 359.     CrossRef
Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV–HIV co-infected patients before and after interferon alpha therapy: A prospective study
Alicia Lowenstein, Hugo Fainboim, Adriana Reyes, Cynthia Lutzky, Beatriz Ameigeiras, Teresa Schroder, Maria Laura Eugenio Russmann
Endocrinología, Diabetes y Nutrición.2020; 67(4): 263.     CrossRef
Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era
Suk-Jin Hong, Byung-Ho Choe
Clinical and Experimental Pediatrics.2020; 63(2): 46.     CrossRef
Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV–HIV co-infected patients before and after interferon alpha therapy: A prospective study
Alicia Lowenstein, Hugo Fainboim, Adriana Reyes, Cynthia Lutzky, Beatriz Ameigeiras, Teresa Schroder, Maria Laura Eugenio Russmann
Endocrinología, Diabetes y Nutrición (English ed.).2020; 67(4): 263.     CrossRef
Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan
Yu-Kang Chang, Yuan-Tsung Tseng, Kou-Huang Chen, Kow-Tong Chen
BMC Endocrine Disorders.2019;[Epub]     CrossRef
Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin
Daniele Serranti, Giuseppe Indolfi, Gabriella Nebbia, Mara Cananzi, Lorenzo D’Antiga, Silvia Ricci, Stefano Stagi, Chiara Azzari, Massimo Resti
Pediatric Infectious Disease Journal.2018; 37(4): 287.     CrossRef
Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C
Jae-Won Lee, Won Kim, Eun-Kyung Kwon, Yuri Kim, Hyun Mu Shin, Dong-Hyun Kim, Chan-Ki Min, Ji-Yeob Choi, Won-Woo Lee, Myung-Sik Choi, Byeong Gwan Kim, Nam-Hyuk Cho, Eui-Cheol Shin
PLOS ONE.2017; 12(6): e0179094.     CrossRef
Clinical pharmacology profile of care in Hepatology clinic
Talita Rocha Passos, Fabiana Silva Santos, Maria Cleusa Martins, Vanusa Barbosa Pinto, Flair José Carrilho, Suzane Kioko Ono
Revista da Associação Médica Brasileira.2017; 63(5): 401.     CrossRef
Peginterferon-α-2a/peginterferon-α-2b
Reactions Weekly.2016; 1629(1): 199.     CrossRef